These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 18332084)
1. Aldehyde oxidase-catalyzed metabolism of N1-methylnicotinamide in vivo and in vitro in chimeric mice with humanized liver. Kitamura S; Nitta K; Tayama Y; Tanoue C; Sugihara K; Inoue T; Horie T; Ohta S Drug Metab Dispos; 2008 Jul; 36(7):1202-5. PubMed ID: 18332084 [TBL] [Abstract][Full Text] [Related]
2. Estimation of aldehyde oxidase activity in vivo from conversion ratio of N1-methylnicotinamide to pyridones, and intraspecies variation of the enzyme activity in rats. Sugihara K; Tayama Y; Shimomiya K; Yoshimoto D; Ohta S; Kitamura S Drug Metab Dispos; 2006 Feb; 34(2):208-12. PubMed ID: 16299165 [TBL] [Abstract][Full Text] [Related]
3. Developmental changes of aldehyde oxidase in postnatal rat liver. Tayama Y; Moriyasu A; Sugihara K; Ohta S; Kitamura S Drug Metab Pharmacokinet; 2007 Apr; 22(2):119-24. PubMed ID: 17495419 [TBL] [Abstract][Full Text] [Related]
4. Human Aldehyde Oxidase 1-Mediated Carbazeran Oxidation in Chimeric TK-NOG Mice Transplanted with Human Hepatocytes. Uehara S; Yoneda N; Higuchi Y; Yamazaki H; Suemizu H Drug Metab Dispos; 2020 Jul; 48(7):580-586. PubMed ID: 32357972 [TBL] [Abstract][Full Text] [Related]
5. Current status of prediction of drug disposition and toxicity in humans using chimeric mice with humanized liver. Kitamura S; Sugihara K Xenobiotica; 2014 Jan; 44(2):123-34. PubMed ID: 24329499 [TBL] [Abstract][Full Text] [Related]
6. Developmental changes of aldehyde oxidase activity and protein expression in human liver cytosol. Tayama Y; Sugihara K; Sanoh S; Miyake K; Kitamura S; Ohta S Drug Metab Pharmacokinet; 2012; 27(5):543-7. PubMed ID: 22453079 [TBL] [Abstract][Full Text] [Related]
7. CYP2C9-catalyzed metabolism of S-warfarin to 7-hydroxywarfarin in vivo and in vitro in chimeric mice with humanized liver. Inoue T; Nitta K; Sugihara K; Horie T; Kitamura S; Ohta S Drug Metab Dispos; 2008 Dec; 36(12):2429-33. PubMed ID: 18784266 [TBL] [Abstract][Full Text] [Related]
8. Chimeric mice with humanized liver. Katoh M; Tateno C; Yoshizato K; Yokoi T Toxicology; 2008 Apr; 246(1):9-17. PubMed ID: 18248870 [TBL] [Abstract][Full Text] [Related]
9. Prediction of human metabolism of the sedative-hypnotic zaleplon using chimeric mice transplanted with human hepatocytes. Tanoue C; Sugihara K; Uramaru N; Tayama Y; Watanabe Y; Horie T; Ohta S; Kitamura S Xenobiotica; 2013 Nov; 43(11):956-62. PubMed ID: 23651075 [TBL] [Abstract][Full Text] [Related]
10. Enzymes that control the conversion of L-tryptophan-nicotinamide and the urinary excretion ratio (N(1)-methyl-2-pyridone-5-carboxamide + N(1)-methyl-4-pyridone-3-carboxamide)/N(1)-methylnicotinamide in mice. Shibata K; Morita N; Shibata Y; Fukuwatari T Biosci Biotechnol Biochem; 2013; 77(10):2105-11. PubMed ID: 24096677 [TBL] [Abstract][Full Text] [Related]
11. In vivo drug metabolism model for human cytochrome P450 enzyme using chimeric mice with humanized liver. Katoh M; Sawada T; Soeno Y; Nakajima M; Tateno C; Yoshizato K; Yokoi T J Pharm Sci; 2007 Feb; 96(2):428-37. PubMed ID: 17051594 [TBL] [Abstract][Full Text] [Related]
12. Correlation between niacin equivalent intake and urinary excretion of its metabolites, N'-methylnicotinamide, N'-methyl-2-pyridone-5-carboxamide, and N'-methyl-4-pyridone-3-carboxamide, in humans consuming a self-selected food. Shibata K; Matsuo H Am J Clin Nutr; 1989 Jul; 50(1):114-9. PubMed ID: 2526576 [TBL] [Abstract][Full Text] [Related]
13. Prediction of human metabolism of FK3453 by aldehyde oxidase using chimeric mice transplanted with human or rat hepatocytes. Sanoh S; Nozaki K; Murai H; Terashita S; Teramura T; Ohta S Drug Metab Dispos; 2012 Jan; 40(1):76-82. PubMed ID: 21984595 [TBL] [Abstract][Full Text] [Related]
14. A novel ring oxidation of 4- or 5-substituted 2H-oxazole to corresponding 2-oxazolone catalyzed by cytosolic aldehyde oxidase. Arora VK; Philip T; Huang S; Shu YZ Drug Metab Dispos; 2012 Sep; 40(9):1668-76. PubMed ID: 22621803 [TBL] [Abstract][Full Text] [Related]
15. Prediction of in vivo hepatic clearance and half-life of drug candidates in human using chimeric mice with humanized liver. Sanoh S; Horiguchi A; Sugihara K; Kotake Y; Tayama Y; Ohshita H; Tateno C; Horie T; Kitamura S; Ohta S Drug Metab Dispos; 2012 Feb; 40(2):322-8. PubMed ID: 22048522 [TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of metabolites of ASP015K, a novel oral Janus kinase inhibitor, in rats, chimeric mice with humanized liver, and humans. Nakada N; Oda K Xenobiotica; 2015; 45(9):757-65. PubMed ID: 25869242 [TBL] [Abstract][Full Text] [Related]
18. Significance of aldehyde oxidase during drug development: Effects on drug metabolism, pharmacokinetics, toxicity, and efficacy. Sanoh S; Tayama Y; Sugihara K; Kitamura S; Ohta S Drug Metab Pharmacokinet; 2015 Feb; 30(1):52-63. PubMed ID: 25760530 [TBL] [Abstract][Full Text] [Related]
19. Differences in aldehyde oxidase activity in cytosolic preparations of human and monkey liver. Sugihara K; Kitamura S; Tatsumi K; Asahara T; Dohi K Biochem Mol Biol Int; 1997 May; 41(6):1153-60. PubMed ID: 9161710 [TBL] [Abstract][Full Text] [Related]
20. Alleviation of fatty liver in a rat model by enhancing N Takeuchi K; Yokouchi C; Goto H; Umehara K; Yamada H; Ishii Y Biochem Biophys Res Commun; 2018 Dec; 507(1-4):203-210. PubMed ID: 30446221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]